How AI Could Increase Clinical Trial Enrollment in Adults With Cancer
Summary by JAMA Network
1 Articles
1 Articles
How AI Could Increase Clinical Trial Enrollment in Adults With Cancer
Enrolling adults with cancer in clinical trials has historically been challenging, despite the critical role these trials play in developing new cancer treatments. To address this challenge, investigators at the Dana-Farber Cancer Institute (DFCI) developed an artificial intelligence (AI) tool that could make it easier to identify individuals who are eligible for clinical trials, potentially increasing enrollment as well.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium